Concepedia
Statistics
Publications
16
Citations
580
H-Index
12
Active since
2002
Affiliations
AbbVie (United States)(Current)
GlaxoSmithKline (United Kingdom)
AstraZeneca (United Kingdom)
University of Illinois Urbana-Champaign
Takeda (United States)
Jeffrey M. Kallemeyn is an author at AbbVie (United States) specializing in chemistry, natural sciences, and organic chemistry.
Publications per year
2002–2023
Palladium-Catalyzed Silylation of Aryl Bromides Leading to Functionalized Aryldimethylsilanols
Scott E. Denmark, Jeffrey M. Kallemeyn · Organic Letters · 2003 · 109 citations
Natural Sciences, Chemistry, Catalysis +9
Synthesis of 3,4,5-Trisubstituted Isoxazoles via Sequential [3 + 2] Cycloaddition/Silicon-Based Cross-Coupling Reactions
Scott E. Denmark, Jeffrey M. Kallemeyn · The Journal of Organic Chemistry · 2005 · 91 citations
Natural Sciences, Chemistry, Medicinal Chemistry +13
Stereospecific Palladium-Catalyzed Cross-Coupling of (<i>E</i>)- and (<i>Z</i>)-Alkenylsilanolates with Aryl Chlorides
Scott E. Denmark, Jeffrey M. Kallemeyn · Journal of the American Chemical Society · 2006 · 82 citations
Natural Sciences, Chemistry, Catalysis +14
Development of an Enantioselective [3 + 2] Cycloaddition To Synthesize the Pyrrolidine Core of ABBV-3221 on Multikilogram Scale
J. B. Hartung, Stephen N. Greszler, Russell C. Klix et al. · Organic Process Research & Development · 2019 · 42 citations
Natural Sciences, Chemistry, Catalysis +13
Development of the Enabling Route for Glecaprevir via Ring-Closing Metathesis
Russell D. Cink, K. A. LUKIN, Richard D. Bishop et al. · Organic Process Research & Development · 2019 · 37 citations
Pharmacy, Medicinal Chemistry, Pharmacology +17
1–5 of 16